Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2026-02-19 @ 2:50 AM
Study NCT ID:
NCT00068757
Status:
COMPLETED
Last Update Posted:
2012-09-12
First Post:
2003-09-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
Sponsor:
Organization: